Literature DB >> 22366302

Structural determinants of MALT1 protease activity.

Christian Wiesmann1, Lukas Leder, Jutta Blank, Anna Bernardi, Samu Melkko, Arnaud Decock, Allan D'Arcy, Frederic Villard, Paulus Erbel, Nicola Hughes, Felix Freuler, Rainer Nikolay, Juliano Alves, Frederic Bornancin, Martin Renatus.   

Abstract

The formation of the CBM (CARD11-BCL10-MALT1) complex is pivotal for antigen-receptor-mediated activation of the transcription factor NF-κB. Signaling is dependent on MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1), which not only acts as a scaffolding protein but also possesses proteolytic activity mediated by its caspase-like domain. It remained unclear how the CBM activates MALT1. Here, we provide biochemical and structural evidence that MALT1 activation is dependent on its dimerization and show that mutations at the dimer interface abrogate activity in cells. The unliganded protease presents itself in a dimeric yet inactive state and undergoes substantial conformational changes upon substrate binding. These structural changes also affect the conformation of the C-terminal Ig-like domain, a domain that is required for MALT1 activity. Binding to the active site is coupled to a relative movement of caspase and Ig-like domains. MALT1 binding partners thus may have the potential of tuning MALT1 protease activity without binding directly to the caspase domain.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366302     DOI: 10.1016/j.jmb.2012.02.018

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  34 in total

1.  Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation.

Authors:  Elfriede Dall; Hans Brandstetter
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

2.  MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo.

Authors:  Lorena Fontan; Chenghua Yang; Venkataraman Kabaleeswaran; Laurent Volpon; Michael J Osborne; Elena Beltran; Monica Garcia; Leandro Cerchietti; Rita Shaknovich; Shao Ning Yang; Fang Fang; Randy D Gascoyne; Jose Angel Martinez-Climent; J Fraser Glickman; Katherine Borden; Hao Wu; Ari Melnick
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

Review 3.  The CBM signalosome: potential therapeutic target for aggressive lymphoma?

Authors:  Chenghua Yang; Liron David; Qi Qiao; Ermelinda Damko; Hao Wu
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

4.  Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domain.

Authors:  Rebekka Schairer; Gareth Hall; Ming Zhang; Richard Cowan; Roberta Baravalle; Frederick W Muskett; Peter J Coombs; Chido Mpamhanga; Lisa R Hale; Barbara Saxty; Justyna Iwaszkiewicz; Chantal Décaillet; Mai Perroud; Mark D Carr; Margot Thome
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-24       Impact factor: 11.205

5.  MALT1 is not alone after all: identification of novel paracaspases.

Authors:  Paco Hulpiau; Yasmine Driege; Jens Staal; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2015-09-16       Impact factor: 9.261

6.  The protease activity of the paracaspase MALT1 is controlled by monoubiquitination.

Authors:  Christiane Pelzer; Katrin Cabalzar; Annette Wolf; Montserrat Gonzalez; Georg Lenz; Margot Thome
Journal:  Nat Immunol       Date:  2013-02-17       Impact factor: 25.606

Review 7.  A primer on caspase mechanisms.

Authors:  Monica L Gonzalez Ramirez; Guy S Salvesen
Journal:  Semin Cell Dev Biol       Date:  2018-01-12       Impact factor: 7.727

8.  Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.

Authors:  Lorena Fontán; Qi Qiao; John M Hatcher; Gabriella Casalena; Ilkay Us; Matt Teater; Matt Durant; Guangyan Du; Min Xia; Natalia Bilchuk; Spandan Chennamadhavuni; Giuseppe Palladino; Giorgio Inghirami; Ulrike Philippar; Hao Wu; David A Scott; Nathanael S Gray; Ari Melnick
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

Review 9.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

10.  Secondary Metabolites from the Fungus Dictyosporium sp. and Their MALT1 Inhibitory Activities.

Authors:  Trong D Tran; Brice A P Wilson; Curtis J Henrich; Louis M Staudt; Lauren R H Krumpe; Emily A Smith; Jarrod King; Karen L Wendt; Alberto M Stchigel; Andrew N Miller; Robert H Cichewicz; Barry R O'Keefe; Kirk R Gustafson
Journal:  J Nat Prod       Date:  2019-01-02       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.